ARENA PHARMACEUTICALS INC

• SAN DIEGO, CA How do I update this listing?

Create Email Alert

Arena Pharmaceuticals is based out of San Diego. Seeks to discover, develop and commercialize novel and improved orally available drugs. Focuses efforts across G protein-coupled receptor targets and compounds within four therapeutic areas: metabolic diseases, central nervous system disorders, cardiovascular diseases and inflammatory disorders.Whalewisdom has at least 1 13G filings, and 133 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2010-06-21. The notice included securities offered of Equity

Contact Info

arena pharmaceuticals inc
6166 NANCY RIDGE DR
SAN DIEGO CA    92121
Business Phone: 8584537200
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS
Current 13D/G Holdings
Stock Sector Shares Held Market Value Rank Source Source Date
Longboard Pharmaceuticals Inc (LBPH) HEALTH CARE 3,978,550 19,415,324.00 1 13G 2021-12-31

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2010-06-21 D BIOTECHNOLOGY Equity 35,530,000 35,530,000 0
2009-07-21 D BIOTECHNOLOGY Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 151,760,000 151,760,000 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
CHRISTINE A. WHITE subscription required
    DIRECTOR
DOMINIC P. BEHAN subscription required
    EXECUTIVE OFFICER DIRECTOR
DONALD D. BELCHER subscription required
    DIRECTOR
HARRY F. HIXSON, JR. subscription required
    DIRECTOR
J. CLAYBURN LA FORCE, JR. subscription required
    DIRECTOR
JACK LIEF subscription required
    EXECUTIVE OFFICER DIRECTOR
K.A. AJIT-SIMH subscription required
    EXECUTIVE OFFICER
PHILLIP M. SCHNEIDER subscription required
    DIRECTOR
RANDALL E. WOODS subscription required
    DIRECTOR
ROBERT E. HOFFMAN subscription required
    EXECUTIVE OFFICER
SCOTT H. BICE subscription required
    DIRECTOR
STEVEN W. SPECTOR subscription required
    EXECUTIVE OFFICER
TINA S. NOVA subscription required
    DIRECTOR
WILLIAM R. SHANAHAN, JR. subscription required
    EXECUTIVE OFFICER

Elevate your investments